| ¤³¤¦¤·¤¿Êì»Ò²ÈÄí¤ÎµÞÁýÅù¤Î¿·¤·¤¤»þÂå¤ÎÍ×ÀÁ¤ËÂбþ¤¹¤ë¤¿¤á¡¢Ç¯·î¤ËÊì»ÒµÚ¤Ó²ÉÉØÊ¡»ãË¡Åù¤¬²þÀµ¤µ¤ì¡Ê¡ÊÊ¿À®¡Ëǯ |
| ¤³¤¦¤·¤¿Ãæ¡¢²£É͸¡±Ö½ê¤Ç¤Ï¿·¤¿¤Ê»î¤ß¤ò¹Ô¤Ã¤Æ¤¤¤ë¡£ |
| £¸Âæ¤Î¡ÖÌôʪÍðÍÑËɻߥ¥ã¥é¥Ð¥ó¥«¡¼¡×¤òÍѤ¤¤ÆÁ´¹ñ¤Î¾®¡¦Ã桦¹â¹»¤äÃϰèÅù¤Ë¤ª¤¤¤Æ¸ú²ÌŪ¤Ê·¼È¯³èư¤òŸ³«¤·¤Æ¤¤¤ë¡£ |
| ¤³¤Î¼Ò²ñŪÍ×ÀÁ¤Ë±þ¤¨¤ë¤¿¤á¤Ë¤Ï¡¢Âç³Ø¤ÎÌôºÞ»ÕÍÜÀ®¤Î¤¿¤á¤ÎÌô³Ø¶µ°é¤Ë¤ª¤¤¤Æ¡¢¶µÍܶµ°é¡¢°åÎÅÌô³Ø¡¢¼Â̳¼Â½¬¤ò½¼¼Â¤·¤¿¶µ°é²ÝÄø¤ÎÊÔÀ®¤Ë¤è¤ê¡¢Î×¾²¤Ë·¸¤ë¼ÂÁ©Åª¤ÊǽÎϤòÇݤ¦¤³¤È¤¬É¬ÍפǤ¢¤ë¡£ |
| ¤Þ¤¿¡¢Ã˽÷¤Î¹½À®³ä¹ç¤òÀÊ̤ˤߤë¤È¡¢¤¹¤Ù¤Æ¤ÎǯÎ𳬵é¤ÇŽ¢ÃËŽ£¤ÎÀê¤á¤ë³ä¹ç¤¬Â¿¤¯¤Ê¤Ã¤Æ¤¤¤ë¤¬¡¢Ž¢½÷Ž£¤Î³ä¹ç¤Ï¡¢Ç¯Î𳬵餬Ä㤯¤Ê¤ë¤Û¤É¿¤¯¡¢Ž¢ºÐ°Ê²¼Ž£¤Ç¤Ï¡ó¤È¤Ê¤Ã¤Æ¤¤¤ë¡£ |
| £·¡Ë½¾»öÀè¤Î½êºßÃÏ¡Ê |
| ¤Þ¤¿¡¢¢¤Î¤è¤¦¤Ê¾ì¹ç¡¢¸¡±Ö½ê¤Ë¤ª¤±¤ëÍ¢Æþ»þ¤Î´Æ»ë¤È¹ñÆâ´Æ»ë¤È¤ÎÏ¢·È¶¯²½¤Ë¤è¤ëÆó½Å´Æ»ëÂÎÀ©¤Ë¤è¤Ã¤Æ¡¢°ãÈ¿¿©Éʤδƻë¤ò¤è¤êŰÄ줷¡¢°ÂÁ´¤Î³ÎÊݤò¹Ô¤¦¤³¤È¤¬½ÅÍפˤʤ롣 |
| ¡Ë¤Ë¤è¤ë°åÎÅ»ö¸Î¤¬ÉÑȯ¤¹¤ëÍ×°ø¤È¤Ê¤Ã¤Æ¤¤¤ë¡£ |
| ¸ú²Ì¤Îɾ²ÁÊýË¡¤È¤·¤ÆºÇ¤â¿®ÍêÀ¤Î¹â¤¤¤Î¤Ï̵ºî°Ù²½Èæ³ÓÎ×¾²»î¸³¡ÊRandomizedControlledTrial:RCT¡Ë¤Ç¤¢¤ê¡¢¸½ºß¤Þ¤Ç¤Ëɾ²Á¤µ¤ì¤¿¤¬¤ó¸¡¿Ç¤Î·ë²Ì¤Ïɽ¤Î¤È¤ª¤ê¤Ç¤¢¤ë¡£ |
| ½÷À¤ÎϫƯÎÏΨ¤ÏÁ°Ç¯¤è¤ê¡ó¥Ý¥¤¥ó¥ÈÄã²¼¤·¤Æ¡ó¤È¤Ê¤ê¡¢¡ÊÊ¿À®£¹¡Ëǯ¤òĺÅÀ¤È¤·¤ÆÄã²¼¤ò³¤±¤Æ¤¤¤ë¡£ |
| £²Ç¯Î𳬵éÊ̤ˤߤ¿É±¡¤Ë½¾»ö¤¹¤ë°å»Õ¿ôµÚ¤ÓÊ¿¶ÑǯÎð¤Îǯ¼¡¿ä°Ü¿Þ |
| ¡Ê |
| £²³ä¤Ç¤¢¤Ã¤¿¡Ê±ÒÀ¸¶¨²ñÂç¿Ã´±Ë¼Åý·×¾ðÊóÉô¡ÖÊÝ·òÊ¡»ãư¸þÄ´ºº¡×¡Êǯ¡Ë¡Ë¡£ |